VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $401,000 | -96.5% | 16,314 | -74.3% | 0.00% | -100.0% |
| Q3 2015 | $11,304,000 | -46.0% | 63,372 | -32.7% | 0.00% | -33.3% |
| Q2 2015 | $20,915,000 | +23.5% | 94,146 | +10.4% | 0.00% | 0.0% |
| Q1 2015 | $16,939,000 | -14.6% | 85,281 | -38.4% | 0.00% | 0.0% |
| Q4 2014 | $19,826,000 | -13.7% | 138,540 | -20.9% | 0.00% | -25.0% |
| Q3 2014 | $22,971,000 | +38.6% | 175,081 | +33.2% | 0.00% | +33.3% |
| Q2 2014 | $16,578,000 | +21.0% | 131,444 | +26.5% | 0.00% | +50.0% |
| Q1 2014 | $13,696,000 | +5.3% | 103,893 | -6.2% | 0.00% | 0.0% |
| Q4 2013 | $13,007,000 | +13.4% | 110,796 | +0.8% | 0.00% | 0.0% |
| Q3 2013 | $11,465,000 | +42.2% | 109,893 | +17.3% | 0.00% | 0.0% |
| Q2 2013 | $8,061,000 | – | 93,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |